OCGN FY 2024 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$578M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M-32.8% YoY

Gross Profit

$2M51.5% margin

Operating Income

-$55M-1350.4% margin

Net Income

-$54M-1333.0% margin

EPS (Diluted)

$-0.20

Cash Flow

Operating Cash Flow

-$42M

Free Cash Flow

-$46M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$82M

Total Liabilities

$53M

Stockholders' Equity

$30M

Cash & Equivalents

$59M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$6M	-32.8%
Gross Profit	$2M	$5M	-60.9%
Operating Income	-$55M	-$66M	+16.4%
Net Income	-$54M	-$63M	+14.3%